OBJECTIVES

PURPOSE
The purpose of this continuing education activity is to present current management, clinical and research results by experts in the field of diabetes, endocrine disease, and cardiovascular disease.

OBJECTIVES
The intended result of this activity is to provide increased knowledge of diabetes, endocrinology and vascular disease.  At the conclusion of the program, participants will be able to:

• Define and outline treatment strategies for hypogonadism including hormone replacement therapy.
• Understand why excess body fat is linked to a higher risk of cancer, heart disease, diabetes and orthopedic issues – and how to specifically lower your body fat.
• Define diabetes education and the role of the diabetes educator.
• Provide an aggressive treatment plan to achieve A1C goal of <6% with the goal to delay or prevent microvascular and cardiovascular complications.
• Prescribe treatment methods of type 2 diabetes mellitus based upon its pathophysiology – stress the incretin system
• Identify patients with type 2 diabetes mellitus most likely to benefit from early insulin therapy.
• Assess the major risks and benefits of more intensive glycemic control.
• Treat patients with type 2 diabetes to reach an appropriate LDL cholesterol goal and an appropriate non-HDL cholesterol goal.
• Apply specific Hypertension treatment strategies for patients with concomitant co-morbid conditions.
• Summarize the key treatment steps for patients with endocrine hypertension.
• List the different modalities of current therapy for end stage renal disease.
• Define and provide appropriate treatment strategies for thyroid disease.
• Elaborate upon the need for normal autonomic function to prevent sudden death with intense glycemic control.
• Outline the different incretin-based therapies and their effects on diabetes treatment.
• Explain the effect of ectopic fat on metabolic function.